Showing results (51-60 of 765) with videos related to

Sort By:
Pageof 77
Clinical Therapeutics|July 1, 1997
Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effectF C Lowe
The Urologic Clinics of North America|May 1, 1992
Squamous-cell carcinoma of the scrotumF C Lowe
Urology|December 26, 2001
Phytotherapy in the management of benign prostatic hyperplasiaF C Lowe
Urology|January 1, 1985
Squamous cell carcinoma of scrotumF C Lowe
Urology|July 1, 1994
Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysisF C Lowe
The Urologic Clinics of North America|May 1, 1997
Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigenP A Abrahamsson, H Lilja, J E Oesterling
World Journal of Urology|January 1, 1997
Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomyM C Beduschi, R Beduschi, J E Oesterling
Urology|June 3, 1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonistM C Beduschi, R Beduschi, J E Oesterling
The Journal of Urology|April 1, 1986
Xeroradiography and ultrasonography in the evaluation of a penile injuryJ E Oesterling, W D Bromberg, P C Albertsen
The Journal of Urology|May 1, 1994
Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasiaJ M Monda, M J Barry, J E Oesterling
Pageof 77